Un traitement rapide et approprié ainsi qu'une surveillance continue aident à prévenir les complications.
PréventionTraitement rapideSurveillance
Facteurs de risque
5
#1
Quels sont les principaux facteurs de risque ?
Les facteurs incluent le diabète de type 2, l'âge avancé et des infections sévères.
Facteurs de risqueDiabète de type 2Infections
#2
Comment l'âge influence-t-il le risque ?
Les personnes âgées ont un risque accru en raison de la déshydratation et de la comorbidité.
ÂgeDéshydratationComorbidité
#3
Les infections augmentent-elles le risque ?
Oui, les infections peuvent provoquer une décompensation du diabète et augmenter le risque.
InfectionsDécompensationDiabète
#4
Quel rôle joue la médication ?
Certaines médications peuvent affecter le contrôle de la glycémie et augmenter le risque.
MédicationContrôle de la glycémieRisque
#5
Comment l'alimentation influence-t-elle le risque ?
Une alimentation riche en glucides simples peut contribuer à des pics de glycémie et au risque.
AlimentationGlucides simplesGlycémie
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Coma hyperosmolaire hyperglycémique non cétosique : Questions médicales les plus fréquentes",
"headline": "Coma hyperosmolaire hyperglycémique non cétosique : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Coma hyperosmolaire hyperglycémique non cétosique : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-15",
"dateModified": "2026-07-05",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Coma hyperosmolaire hyperglycémique non cétosique"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Coma diabétique",
"url": "https://questionsmedicales.fr/mesh/D003926",
"about": {
"@type": "MedicalCondition",
"name": "Coma diabétique",
"code": {
"@type": "MedicalCode",
"code": "D003926",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C19.246.099.750"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Coma hyperosmolaire hyperglycémique non cétosique",
"alternateName": "Hyperglycemic Hyperosmolar Nonketotic Coma",
"code": {
"@type": "MedicalCode",
"code": "D006944",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Kyosuke Takahashi",
"url": "https://questionsmedicales.fr/author/Kyosuke%20Takahashi",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan; Department of Anesthesiology and Critical Care Medicine, Kawasaki Municipal Hospital, 12-1 Shinkawadori, Kawasaki-ku, Kawasaki, Kanagawa 210-0013, Japan. Electronic address: ktakahashi@cf.em-net.ne.jp."
}
},
{
"@type": "Person",
"name": "Norimichi Uenishi",
"url": "https://questionsmedicales.fr/author/Norimichi%20Uenishi",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency and General Internal Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan."
}
},
{
"@type": "Person",
"name": "Masamitsu Sanui",
"url": "https://questionsmedicales.fr/author/Masamitsu%20Sanui",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan."
}
},
{
"@type": "Person",
"name": "Shigehiko Uchino",
"url": "https://questionsmedicales.fr/author/Shigehiko%20Uchino",
"affiliation": {
"@type": "Organization",
"name": "Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan."
}
},
{
"@type": "Person",
"name": "Naoki Yonezawa",
"url": "https://questionsmedicales.fr/author/Naoki%20Yonezawa",
"affiliation": {
"@type": "Organization",
"name": "Department of Emergency and Critical Care Medicine, Yokohama City Minato Red Cross Hospital, 3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa 231-8682, Japan."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Tacrolimus related diabetic ketoacidosis and hyperglycemic hyperosmolar nonketotic syndrome: an observational, retrospective, pharmacovigilance study.",
"datePublished": "2024-08-16",
"url": "https://questionsmedicales.fr/article/39149847",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14740338.2024.2393278"
}
},
{
"@type": "ScholarlyArticle",
"name": "Persistent hemichoreoathetosis-hemidystonia after nonketotic hyperosmolar hyperglycemia.",
"datePublished": "2023-10-16",
"url": "https://questionsmedicales.fr/article/37927362",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.prdoa.2023.100221"
}
},
{
"@type": "ScholarlyArticle",
"name": "A Case Report and Literature Review of Nonketotic Hyperglycemic Hemichorea.",
"datePublished": "2024-03-13",
"url": "https://questionsmedicales.fr/article/38618383",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.56087"
}
},
{
"@type": "ScholarlyArticle",
"name": "Combined hyperglycemic crises in adult patients already exist in Latin America.",
"datePublished": "2024-05-31",
"url": "https://questionsmedicales.fr/article/39079150",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7705/biomedica.6912"
}
},
{
"@type": "ScholarlyArticle",
"name": "Empagliflozin-Associated Pancreatitis in the Setting of Hyperglycemic Hyperosmolar Syndrome.",
"datePublished": "2024-05-23",
"url": "https://questionsmedicales.fr/article/38910717",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.7759/cureus.60935"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Maladies endocriniennes",
"item": "https://questionsmedicales.fr/mesh/D004700"
},
{
"@type": "ListItem",
"position": 3,
"name": "Diabète",
"item": "https://questionsmedicales.fr/mesh/D003920"
},
{
"@type": "ListItem",
"position": 4,
"name": "Complications du diabète",
"item": "https://questionsmedicales.fr/mesh/D048909"
},
{
"@type": "ListItem",
"position": 5,
"name": "Coma diabétique",
"item": "https://questionsmedicales.fr/mesh/D003926"
},
{
"@type": "ListItem",
"position": 6,
"name": "Coma hyperosmolaire hyperglycémique non cétosique",
"item": "https://questionsmedicales.fr/mesh/D006944"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Coma hyperosmolaire hyperglycémique non cétosique - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Coma hyperosmolaire hyperglycémique non cétosique",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-08-25",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Coma hyperosmolaire hyperglycémique non cétosique",
"description": "Comment diagnostiquer un coma hyperosmolaire ?\nQuels tests sont nécessaires pour le diagnostic ?\nQuels signes cliniques indiquent un coma ?\nQuelle est la différence avec le coma diabétique cétosique ?\nComment évaluer l'état d'hydratation ?",
"url": "https://questionsmedicales.fr/mesh/D006944#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Coma hyperosmolaire hyperglycémique non cétosique",
"description": "Quels sont les symptômes principaux ?\nComment se manifeste la déshydratation ?\nY a-t-il des signes neurologiques ?\nQuels sont les symptômes d'hyperglycémie ?\nComment reconnaître une urgence médicale ?",
"url": "https://questionsmedicales.fr/mesh/D006944#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Coma hyperosmolaire hyperglycémique non cétosique",
"description": "Comment prévenir le coma hyperosmolaire ?\nQuels conseils pour les diabétiques ?\nY a-t-il des recommandations alimentaires ?\nComment gérer le stress pour prévenir ?\nQuelle est l'importance de l'éducation ?",
"url": "https://questionsmedicales.fr/mesh/D006944#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Coma hyperosmolaire hyperglycémique non cétosique",
"description": "Quel est le traitement principal ?\nComment gérer l'hyperosmolarité ?\nQuels médicaments sont utilisés ?\nQuelle est l'importance de la surveillance ?\nQuand est-il nécessaire d'hospitaliser ?",
"url": "https://questionsmedicales.fr/mesh/D006944#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Coma hyperosmolaire hyperglycémique non cétosique",
"description": "Quelles sont les complications possibles ?\nComment le coma affecte-t-il le cerveau ?\nY a-t-il des risques à long terme ?\nQuels sont les effets sur les organes ?\nComment prévenir les complications ?",
"url": "https://questionsmedicales.fr/mesh/D006944#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Coma hyperosmolaire hyperglycémique non cétosique",
"description": "Quels sont les principaux facteurs de risque ?\nComment l'âge influence-t-il le risque ?\nLes infections augmentent-elles le risque ?\nQuel rôle joue la médication ?\nComment l'alimentation influence-t-elle le risque ?",
"url": "https://questionsmedicales.fr/mesh/D006944#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer un coma hyperosmolaire ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur des tests de glycémie, d'osmolarité et d'évaluation clinique."
}
},
{
"@type": "Question",
"name": "Quels tests sont nécessaires pour le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des analyses de sang pour la glycémie, l'osmolarité et les électrolytes sont essentielles."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques indiquent un coma ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Confusion, somnolence, déshydratation et signes neurologiques sont des indicateurs clés."
}
},
{
"@type": "Question",
"name": "Quelle est la différence avec le coma diabétique cétosique ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le coma cétosique présente des cétones dans l'urine, tandis que le coma hyperosmolaire n'en a pas."
}
},
{
"@type": "Question",
"name": "Comment évaluer l'état d'hydratation ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'évaluation se fait par l'examen physique et des tests de laboratoire pour les électrolytes."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes principaux ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent soif intense, urination fréquente, confusion et faiblesse."
}
},
{
"@type": "Question",
"name": "Comment se manifeste la déshydratation ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "La déshydratation se manifeste par une peau sèche, une bouche sèche et une fatigue accrue."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes neurologiques ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des signes comme la confusion, des convulsions ou un coma peuvent survenir."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'hyperglycémie ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent fatigue, vision floue, et mictions fréquentes."
}
},
{
"@type": "Question",
"name": "Comment reconnaître une urgence médicale ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une détérioration rapide de l'état mental ou des signes de choc nécessitent une attention immédiate."
}
},
{
"@type": "Question",
"name": "Comment prévenir le coma hyperosmolaire ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par un contrôle rigoureux de la glycémie et une hydratation adéquate."
}
},
{
"@type": "Question",
"name": "Quels conseils pour les diabétiques ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les diabétiques doivent surveiller régulièrement leur glycémie et rester bien hydratés."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations alimentaires ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée et pauvre en sucres rapides aide à prévenir les pics de glycémie."
}
},
{
"@type": "Question",
"name": "Comment gérer le stress pour prévenir ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des techniques de gestion du stress, comme la méditation, peuvent aider à contrôler la glycémie."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de l'éducation ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'éducation des patients sur la gestion du diabète est essentielle pour prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement principal est l'hydratation intraveineuse et l'insuline pour réduire la glycémie."
}
},
{
"@type": "Question",
"name": "Comment gérer l'hyperosmolarité ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hyperosmolarité est gérée par une réhydratation progressive et un contrôle de la glycémie."
}
},
{
"@type": "Question",
"name": "Quels médicaments sont utilisés ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'insuline est le principal médicament, parfois accompagnée d'électrolytes pour la correction."
}
},
{
"@type": "Question",
"name": "Quelle est l'importance de la surveillance ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une surveillance étroite des signes vitaux et des niveaux de glucose est cruciale."
}
},
{
"@type": "Question",
"name": "Quand est-il nécessaire d'hospitaliser ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hospitalisation est nécessaire en cas de coma, déshydratation sévère ou complications."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des lésions cérébrales, des troubles électrolytiques et un choc."
}
},
{
"@type": "Question",
"name": "Comment le coma affecte-t-il le cerveau ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le coma peut entraîner des lésions cérébrales permanentes dues à un manque d'oxygène."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques à long terme ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des problèmes cognitifs et neurologiques peuvent persister après un coma."
}
},
{
"@type": "Question",
"name": "Quels sont les effets sur les organes ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les organes peuvent subir des dommages dus à une déshydratation sévère et à des déséquilibres électrolytiques."
}
},
{
"@type": "Question",
"name": "Comment prévenir les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un traitement rapide et approprié ainsi qu'une surveillance continue aident à prévenir les complications."
}
},
{
"@type": "Question",
"name": "Quels sont les principaux facteurs de risque ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent le diabète de type 2, l'âge avancé et des infections sévères."
}
},
{
"@type": "Question",
"name": "Comment l'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes âgées ont un risque accru en raison de la déshydratation et de la comorbidité."
}
},
{
"@type": "Question",
"name": "Les infections augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les infections peuvent provoquer une décompensation du diabète et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Quel rôle joue la médication ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines médications peuvent affecter le contrôle de la glycémie et augmenter le risque."
}
},
{
"@type": "Question",
"name": "Comment l'alimentation influence-t-elle le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en glucides simples peut contribuer à des pics de glycémie et au risque."
}
}
]
}
]
}
Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan; Department of Anesthesiology and Critical Care Medicine, Kawasaki Municipal Hospital, 12-1 Shinkawadori, Kawasaki-ku, Kawasaki, Kanagawa 210-0013, Japan. Electronic address: ktakahashi@cf.em-net.ne.jp.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Emergency and General Internal Medicine, Fujita Health University School of Medicine, 1-98 Dengakugakubo, Kutsukake-cho, Toyoake, Aichi 470-1192, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Anesthesiology and Critical Care Medicine, Jichi Medical University Saitama Medical Center, 1-847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Emergency and Critical Care Medicine, Yokohama City Minato Red Cross Hospital, 3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa 231-8682, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Emergency and Critical Care Medicine, Yokohama City Minato Red Cross Hospital, 3-12-1 Shinyamashita, Naka-ku, Yokohama, Kanagawa 231-8682, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Preventive Services, Kyoto University Graduate School of Medicine, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Division of Nephrology, Department of Internal Medicine, Okinawa Prefectural Chubu Hospital, 281 Miyazato, Uruma, Okinawa 904-2293, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Critical Care Medicine, Sunnybrook Health Sciences Centre, 2075 Bayview Ave, Toronto, Ontario M4N 3M5, Canada; Interdepartmental Division of Critical Care Medicine, University of Toronto, 27 King's College Cir, Toronto, ON M5S, Canada; Department of Intensive Care Medicine, Kameda Medical Center, 929 Higashi-cho, Kamogawa, Chiba 296-8602, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Emergency Medicine, International University of Health and Welfare Narita Hospital, 852 Hatakeda Narita, Chiba 286-0124, Japan; Department of Emergency Medicine, Kumamoto Red Cross Hospital, Higashi, 2-1-1, Nagamineminami, Higashi-ku, Kumamoto 861-8520, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Emergency Medicine, Musashino Red Cross Hospital, 1-26-1 Kyonancho, Musashino, Tokyo 180-8610, Japan; Department of Emergency Medicine, Jichi Medical University Saitama Medical Center, 847 Amanumacho, Omiya-ku, Saitama-city, Saitama 330-0834, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Medicine, Nerima Hikarigaoka Hospital, 2-5-1 Hikarigaoka, Nerima-ku, Tokyo 179-0072, Japan; Department of Medicine, Taito Municipal Taito Hospital, 3-20-5 Senzoku, Taito-ku, Tokyo 111-0031, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Emergency and Critical Care Medicine, National Hospital Organization Nagoya Medical Center, 4-1-1 Sannomaru, Naka-ku, Nagoya, Aichi 460-0001, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Sports Medicine, Faculty of Medicine, Juntendo University, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan; Department of Emergency and Critical Care Medicine, Juntendo University Nerima Hospital, 3-1-10 Takanodai, Nerima-ku, Tokyo 177-8521, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Pharmacoepidemiology, Graduate School of Medicine and Public Health, Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan; Department of General Internal Medicine, Tottori Prefectural Central Hospital, 730 Ezu, Tottori 680-0901, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Department of Emergency Medicine, Hyogo Emergency Medical Center, 1-3 Wakinohamakaigandori, Chuo-ku, Kobe, Hyogo 651-0073, Japan; Department of Emergency Medicine, Saiseikai Senri Hospital, 1-1-6 Tsukumodai, Suita, Osaka 565-0862, Japan.
Publications dans "Coma hyperosmolaire hyperglycémique non cétosique" :
Information on the incidence and risk factors for diabetic ketoacidosis (DKA) and hyperglycemic hyperosmolar nonketotic syndrome (HHNS) caused by tacrolimus has rarely been reported. This study aims t...
We conducted an observational, retrospective pharmacovigilance study using the Food and Drug Administration adverse event reporting system (FAERS) database. We employed the information component (IC) ...
A total of 232 events were identified as tacrolimus-related DKA/HHNS, 186 cases from DKA and 54 cases from HHNS. The frequency of tacrolimus-associated DKA and HHNS was found to be significantly highe...
Our study showed that DKA and HHNS were associated with tacrolimus use. Healthcare professionals should be aware of the possibility of DKA/HHNS following tacrolimus administration, as they were associ...
Most commonly, hemichorea associated with nonketotic and ketotic hyperglycemia resolves with normalization of blood glucose. Herein, we present a case of hyperosmolar hyperglycemic left hemichoreoathe...
Nonketogenic hyperglycemic hemichorea, also recognized as diabetic striatopathy, is a rare manifestation of diabetes mellitus. The diagnosis of nonketotic hyperglycemic hemichorea is usually made thro...
Diabetes mellitus is one of the most common diseases worldwide, with a high morbidity and mortality rate. Its prevalence has been increasing, as well as its acute complications, such as hyperglycemic ...
To describe the characteristics, outcomes, and complications of the diabetic population with hyperglycemic crises and to value the combined state in the Latin American population....
Retrospective observational study of all hyperglycemic crises treated in the intensive care unit of the Fundación Valle del Lili between January 1, 2015, and December 31, 2020. Descriptive analysis an...
There were 317 patients with confirmed hyperglycemic crises, 43 (13.56%) with diabetic ketoacidosis, 9 (2.83%) in hyperosmolar state, and 265 (83.59%) with combined diabetic ketoacidosis and hyperosmo...
The combined state was the most prevalent presentation of the hyperglycemic crisis, with a mortality rate similar to diabetic ketoacidosis. Invasive mechanical ventilation was associated with a higher...
Acute pancreatitis is a prevalent gastrointestinal condition in the United States, with approximately 130,000 new cases annually, displaying a rising incidence. Severe cases, constituting 20% of insta...
Diazoxide is a commonly used first-line medication for the treatment of hyperinsulinism. Hyperglycemia may occur with diazoxide use. However, hyperglycemic hyperosmolar state (HHS) secondary to diazox...
The hyperosmolar hyperglycemic state (HHS) is a rare and life-threatening complication of diabetes. We aimed to estimate the incidence of HHS and describe the clinical and biomarker profiles of patien...
This nationwide, descriptive cohort study used Danish registry data during years 2016-2018 to identify acutely admitted patients fulfilling the hyperglycemia and hyperosmolarity criteria of HHS (gluco...
We identified 634 patients (median age, 69 years (first quartile; third quartile: 58; 79) who met the criteria of HHS among 4.80 million inhabitants aged ≥18 years. The incidence rates were 16.5 and 3...
The incidence of HHS was higher among patients with type 1 diabetes compared with type 2 diabetes. HHS is a spectrum of hyperglycemic crises and can be divided in pure HHS and HHS-DKA. In one-third of...
Hyperosmolar hyperglycemic state (HHS) is the most serious emergency in patients with uncontrolled diabetes mellitus. It has been associated with a prothrombotic state that increases the risk for isch...
Previous research has indicated that hypoglycemia during hospitalization is a predictor of unfavorable outcomes in patients with diabetes. However, no studies have examined the long-term impact of hyp...
This retrospective cohort study included 170 patients (82 men [48.2%], median age 72 years) admitted to a university hospital for hyperosmolar hyperglycemic crises, including pure hyperosmolar hypergl...
Both hypoglycemia during the initial intravenous insulin therapy phase (observed in 26.5% of patients) and hypoglycemia during the later subcutaneous insulin therapy phase (observed in 52.7% of patien...
Hypoglycemia during hyperosmolar hyperglycemic crises is a marker of long-term mortality, especially when it occurs during the initial intravenous insulin therapy phase....
We compare in-hospital complications in youth with isolated diabetic ketoacidosis (DKA) to youth with hyperosmolarity....
We reviewed medical records of youth (1-20 years) admitted over two years with DKA, hyperglycemic hyperosmolar state (HHS), and hyperosmolar DKA. We evaluated outcomes, including hospital length of st...
Of 369 admissions, 334 had isolated DKA, 32 had hyperosmolar DKA, and three had isolated HHS. Hyperosmolar youth had longer length of stay, larger initial fluid boluses, more frequent pediatric intens...
In youth with DM, hyperosmolarity increases acute complications compared with isolated DKA. Larger-scale studies are needed to identify ways to prevent acute complications in youth experiencing hyperg...